Gruop | Including people (N = 32,482) | Excluding people (N = 69,028) | Total (N = 101,510) | P value |
---|---|---|---|---|
Male, n(%) | 24,502 (75.4) | 56,608 (82.0) | 81,110 (79.9) | < 0.0001 |
Age, year | 46.6 ± 11.3 | 54.4 ± 12.5 | 51.9 ± 12.7 | < 0.0001 |
SBP1, mm Hg | 127 ± 18.9 | 133 ± 21.8 | 131 ± 21.1 | < 0.0001 |
SBP2, mm Hg | 128 ± 18.7 | 135 ± 21.8 | 132 ± 21.1 | < 0.0001 |
SBP3, mm Hg | 129 ± 18.1 | 134 ± 20.6 | 131 ± 19.6 | < 0.0001 |
SBP4, mm Hg | 129 ± 18.3 | 135 ± 20.4 | 132 ± 19.6 | < 0.0001 |
SBP5, mm Hg | 136 ± 19.7 | 141 ± 21.3 | 138 ± 20.5 | < 0.0001 |
BMI, kg/m2 | 25.1 ± 3.47 | 25.0 ± 3.51 | 25.0 ± 3.49 | 0.432 |
HR, beat/min | 73.4 ± 9.78 | 74.0 ± 10.4 | 73.8 ± 10.2 | < 0.0001 |
TC, mmol/L | 4.89 ± 1.14 | 4.98 ± 1.15 | 4.95 ± 1.15 | < 0.0001 |
Hypertension, n(%) | 11,698 (36.0) | 32,957 (47.7) | 44,655 (44.0) | < 0.0001 |
Smoke, n(%) | 11,205 (34.5) | 22,590 (32.7) | 33,795 (33.3) | < 0.0001 |
Salt intake, n(%) | 3387 (10.4) | 7148 (10.4) | 10,535 (10.4) | 0.724 |
Drink, n(%) | 5557 (17.1) | 12,038 (17.4) | 17,595 (17.3) | 0.198 |
Exercise, n(%) | 4228 (13.0) | 11,053 (16.0) | 15,281 (15.1) | < 0.0001 |
antihypertensive drugs, n(%) | 2372 (7.3) | 8942 (13.0) | 11,314 (11.1) | < 0.0001 |
Dm, n(%) | 2195 (6.8) | 7128 (10.3) | 9323 (9.2) | < 0.0001 |